Literature DB >> 16762426

Antidepressants and pain.

Juan A Micó1, Denis Ardid, Esther Berrocoso, Alain Eschalier.   

Abstract

Tricyclic antidepressants, together with anticonvulsants, are considered to be first-line drugs for the treatment of neuropathic pain. Antidepressants are analgesic in patients with chronic pain and no concomitant depression, indicating that the analgesic and antidepressant effects occur independently. The analgesia induced by these drugs seems to be centrally mediated but consistent evidence also indicates a peripheral site of action. Several pharmacological mechanisms account for their antinociceptive effect but the inhibition of monoamine transporters (and, consequently, the facilitation of descending inhibition pain systems) is implicated on the basis of mechanistic and knockout-mouse studies. However, pain is a common symptom of depression, and depression is frequent in chronic pain patients, supporting the hypothesis that pain and depression share some common biochemical mechanisms. We suggest that antidepressants have a genuine analgesic effect and that research into their mechanisms of action will help to facilitate the development of new drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762426     DOI: 10.1016/j.tips.2006.05.004

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  93 in total

1.  Disrupting 5-HT(2A) receptor/PDZ protein interactions reduces hyperalgesia and enhances SSRI efficacy in neuropathic pain.

Authors:  Xavier Pichon; Anne S Wattiez; Carine Becamel; Ingrid Ehrlich; Joel Bockaert; Alain Eschalier; Philippe Marin; Christine Courteix
Journal:  Mol Ther       Date:  2010-06-08       Impact factor: 11.454

2.  Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression.

Authors:  Marta Peciña; Amy S B Bohnert; Magdalena Sikora; Erich T Avery; Scott A Langenecker; Brian J Mickey; Jon-Kar Zubieta
Journal:  JAMA Psychiatry       Date:  2015-11       Impact factor: 21.596

Review 3.  Pain and Psychology-A Reciprocal Relationship.

Authors:  Nalini Vadivelu; Alice M Kai; Gopal Kodumudi; Karine Babayan; Manuel Fontes; Matthew M Burg
Journal:  Ochsner J       Date:  2017

4.  Management of painful neuropathies.

Authors:  Harry J Gould
Journal:  Curr Treat Options Neurol       Date:  2007-03       Impact factor: 3.598

5.  Paroxetine alleviates rat limb post-ischemia induced allodynia through GRK2 upregulation in superior cervical ganglia.

Authors:  Jun Tang; Jing Dong; Li Yang; Lingqi Gao; Jijian Zheng
Journal:  Int J Clin Exp Med       Date:  2015-02-15

6.  An altered spinal serotonergic system contributes to increased thermal nociception in an animal model of depression.

Authors:  Antonio Rodríguez-Gaztelumendi; María Luisa Rojo; Angel Pazos; Alvaro Díaz
Journal:  Exp Brain Res       Date:  2014-03-01       Impact factor: 1.972

7.  Mechanical and cold hypersensitivity in nerve-injured C57BL/6J mice is not associated with fear-avoidance- and depression-related behaviour.

Authors:  F S Hasnie; V C J Wallace; K Hefner; A Holmes; A S C Rice
Journal:  Br J Anaesth       Date:  2007-05-03       Impact factor: 9.166

8.  Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: behavioral and neurobiological analyses.

Authors:  Ying Xu; Lu Zhang; Tuo Shao; Lina Ruan; Lin Wang; Jiao Sun; Jianxin Li; Xinbo Zhu; James M O'Donnell; Jianchun Pan
Journal:  Metab Brain Dis       Date:  2013-04-14       Impact factor: 3.584

9.  Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia.

Authors:  Yohann Bohren; Dzenan Karavelic; Luc-Henri Tessier; Ipek Yalcin; Claire Gavériaux-Ruff; Brigitte L Kieffer; Marie-José Freund-Mercier; Michel Barrot
Journal:  Eur J Pain       Date:  2009-12-28       Impact factor: 3.931

10.  Exacerbated mechanical allodynia in rats with depression-like behavior.

Authors:  Qing Zeng; Shuxing Wang; Grewo Lim; Liling Yang; Ji Mao; Backil Sung; Yang Chang; Jeong-Ae Lim; Gongshe Guo; Jianren Mao
Journal:  Brain Res       Date:  2008-01-26       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.